Pairing CRISPR With Induced Pluripotent Stem Cell Technology Could Be Used To Determine Risk Of A Genetic Variant For CVD, Research Suggests.

CNN (6/18, Howard) reports that new research “demonstrates for the first time how pairing CRISPR with induced pluripotent stem cell technology could be used to determine the risk of a genetic variant for cardiovascular disease.” The findings were publish...